The pharmaceutical industry has increasingly adopted liposomes as a means of drug delivery thanks to their biocompatibility and suitability for both hydrophilic and hydrophobic substrates. A number of factors, such as average diameter, size distribution, and lamellarity (number of bilayers), play a crucial role in determining the drug release profile, and existing batch production methods do not offer the level of control needed for fine-tuning of parameters. More recently, microfluidics has established itself as a desirable alternative, offering consistent particle diameters, narrow size distribution, and good batch-to-batch reproducibility
Channelling the future of liposome generation
Damiano Rossi;
2019-01-01
Abstract
The pharmaceutical industry has increasingly adopted liposomes as a means of drug delivery thanks to their biocompatibility and suitability for both hydrophilic and hydrophobic substrates. A number of factors, such as average diameter, size distribution, and lamellarity (number of bilayers), play a crucial role in determining the drug release profile, and existing batch production methods do not offer the level of control needed for fine-tuning of parameters. More recently, microfluidics has established itself as a desirable alternative, offering consistent particle diameters, narrow size distribution, and good batch-to-batch reproducibilityFile | Dimensione | Formato | |
---|---|---|---|
Channelling the future of liposome generation. Dolomite printed article in EBR Jan 2019.pdf
non disponibili
Tipologia:
Versione finale editoriale
Licenza:
NON PUBBLICO - accesso privato/ristretto
Dimensione
208.32 kB
Formato
Adobe PDF
|
208.32 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.